Since 1973 the World Symposium on Pulmonary Hypertension harmonizes research progresses on pulmonary hypertension.
We are pleased to inform you that the next 7th World Symposium on Pulmonary Hypertension (7th WSPH) will take place in Barcelona, Spain, from Saturday June 29th to Monday July 1st 2024.
Traditionally, the PH World Symposia series, initiated in Geneva in 1973 and held every 5 years after the Evian edition in 1998 (Venice 2003, Dana Point 2008, Nice 2013, Nice 2018), has marked the progress in pulmonary hypertension science and has identified fruitful directions for future developments. The published supplements, including the symposia proceedings, constitute a collection of articles among the most cited in this scientific area.
Each new edition of the WSPH series has experienced an increase in attendance, signifying the growing interest of this field’s stakeholders. More than 1200 international physicians, scientists and other health care workers attended the 5th WSPH – Nice 2013, and more than 1500 attended the 6th WSPH – Nice 2018.
The objectives of the 7th WSPH will be as follows:
15 Task Forces have been identified:
Our purpose is to foster with the Symposium constructive scientific interactions and collaborations in the field of Pulmonary Hypertension.
We look forward to meeting you in Barcelona for this important event.
The Symposium Organizing Committee
He is currently Vice-chairman of the Core Network Pulmonary Hypertension of the European Reference Network—LUNG (ERN-LUNG) under the aegis of the European Commission. He is also coordinator of the Guidelines and best Practice of Care committee of ERN-LUNG. Nazzareno Galiè authored 264 cited publications on heart failure, pulmonary thromboembolic disease and pulmonary hypertension. The SCOPUS H-index is 74. Prof. Galiè has been included in the Thomson Reuters Highly Cited Researchers list in 2014 and 2016 and in the Clarivate Analytics Highly Cited Researchers list in 2017 and 2018.
Prof. McLaughlin is an editorial board member of Chest, a Guest Editor for the Journal of the American College of Cardiology and past Editor-in-Chief of Advances in Pulmonary Hypertension. She is a past Chair of the Scientific Leadership Committee and past Chair of the Board of Trustees of the Pulmonary Hypertension Association, she chaired the American College of Cardiology Foundation/AHA Clinical Expert Consensus Document Committee for Pulmonary Arterial Hypertension and is Co-Principal Investigator of the Pulmonary Hypertension Breakthrough Initiative and Education Fund Steering Committee. She is Topic Working Group Coordinator for the Pulmonary Hypertension Pathway for the American College of Cardiology Annual Scientific Sessions. She is a two time recipient of the Alfred Soffer Research Award.
He is a member of the American Society of Clinical Research, the American Heart Association, the American College of Physicians, the American College of Chest Physicians, and the American Thoracic Society. He is the recipient of the Dickinson Richards Memorial Award from the American Heart Association, the Simon Dack Award from the American College of Cardiology and the Lifetime Achievement Award from the Pulmonary Vascular Research Institute. He was listed among Thomson Reuters’ Most Influential Researchers in the World in 2014 and 2015, and received the CHEST College Medalist Award from the American College of CHEST Physicians in 2016. He also serves on the International Advisory Board for the European Respiratory Journal.
The first one in the New England Journal appeared more than 25 years ago and 20 articles have been published within the last year in international journals. These include the report of the French Registry for Pulmonary Hypertension in the American Journal of Respiratory and Critical Care Medicine on 700 patients with pulmonary artery hypertension referred to the French national network over a 1-year period. Prof. Simonneau earned his medical doctorate in respiratory medicine from the University Paris XII and served as a resident in respiratory and critical care medicine before assuming his academic positions. In 1998 he became Director of Unite Propre de Recherche de l’Enseignement Superieur (UPRES) on pulmonary vascular diseases.
Marc Humbert, MD, PhD, is Dean and Professor of Respiratory Medicine at the Université Paris-Saclay Faculty of Medicine in Le Kremlin-Bicêtre, France. He is the Director of the Respiratory and Intensive Care Medicine Department, French Pulmonary Hypertension Reference Centre (Assistance Publique Hôpitaux de Paris). Marc Humbert is Past President of the European Respiratory Society (ERS) and he was the Chief Editor of the European Respiratory Journal from 2013 to 2017 where he is currently Section Editor in charge of Pulmonary Vascular Medicine. He has received several distinctions including the ERS Cournand Lecture Award, the Rare Disease Award of the Fondation de France and the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension. Marc is the vice-coordinator of the European Reference Network for rare and low prevalence respiratory diseases (ERN-LUNG). Clarivate Analytics has listed Marc Humbert as one of the world's highly cited researchers in the field of Clinical Medicine.
Registration Fees (VAT included)
Registration Fees (VAT included)
Communication of acceptance of abstracts
January 31, 2024
Deadline for refund requests for registrations
May 20, 2024
Online registrations open until
June 20, 2024
No refund will be provided for any cancellation including no-shows
from May 21, 2024
Barcelona is one of the great urban, economic and business centres of Europe, with several connections around the world. The Catalan capital has turned innovation, technological and scientific development, design, commerce, gastronomy and quality services into core elements of its identity.
The extensive and successful experience in organising large events of all kinds and its particular and welcoming character, have made Barcelona one of the three main business tourism destinations in the world and one of the best cities in which to hold a special event.
CVS and e4ethics ID EMT 36574
EthicalMedTech is a unique platform supported by MedTech Europe and dedicated to ethics and compliance projects in the healthcare sector. It is hosting major industry compliance initiatives – including EFPIA’s evaluation platform for European medical conferences since January 2021.
Last time our tickets sold fast so don’t miss.